A Simple and Computationally Efficient Sampling Approach to Covariate Adjustment for Multifactor Dimensionality Reduction Analysis of EpistasisGui J.c · Andrew A.S.c · Andrews P.a, b · Nelson H.M.i · Kelsey K.T.g · Karagas M.R.c · Moore J.H.a-f, h
aComputational Genetics Laboratory, and Departments of bGenetics and cCommunity and Family Medicine, Norris-Cotton Cancer Center, Dartmouth Medical School, Lebanon, N.H., dDepartment of Computer Science, University of New Hampshire, Durham, N.H., eDepartment of Computer Science, University of Vermont, Burlington, Vt., fDepartment of Psychiatry and Human Behavior, and gDepartment of Community Health, Brown University, Providence, R.I., hTranslational Genomics Research Institute, Phoenix, Ariz., and iDivision of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minn., USA
Jason H. Moore, PhD
Computational Genetics Laboratory, Norris-Cotton Cancer Center
Dartmouth Medical School, 706 Rubin Bldg, HB7937, One Medical Center Dr.
Lebanon, NH 03756 (USA)
Tel. +1 603 653 9939, Fax +1 603 653 9900, E-Mail firstname.lastname@example.org
Do you have an account?
Epistasis or gene-gene interaction is a fundamental component of the genetic architecture of complex traits such as disease susceptibility. Multifactor dimensionality reduction (MDR) was developed as a nonparametric and model-free method to detect epistasis when there are no significant marginal genetic effects. However, in many studies of complex disease, other covariates like age of onset and smoking status could have a strong main effect and may potentially interfere with MDR’s ability to achieve its goal. In this paper, we present a simple and computationally efficient sampling method to adjust for covariate effects in MDR. We use simulation to show that after adjustment, MDR has sufficient power to detect true gene-gene interactions. We also compare our method with the state-of-art technique in covariate adjustment. The results suggest that our proposed method performs similarly, but is more computationally efficient. We then apply this new method to an analysis of a population-based bladder cancer study in New Hampshire.
© 2010 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.